Primary progressive ms and steroid treatment

Progressive multifocal leukoencephalopathy (PML) is a serious and often fatal condition caused by a viral infection in the white matter of the brain at multiple locations. It occurs almost exclusively in people with severe immune deficiency, . transplant patients on immunosuppressive medications, or AIDS patients. It is a rare side affect for people taking the MS drug natalizumab/Tysabri. The risk of developing PML is about one in 1,000 for people who taking natalizumab for more than 12 months. The risk increases after 2 years of therapy. Patients with MS should be informed about the risks of natalizumab, including PML, both before treatment and again after 2 years. They will be monitored regularly to identify PML and other potentially serious side effects as early as possible.

Search for: Never Miss Another MS Update! Receive Our Free Newsletter. * indicates required Email Address * First Name Last Name
Featured Posts

  • Back to the World
  • MS Forums Section Added to MS News Today: Join Our Conversation
  • Acute Acalculous Cholecystitis Linked to Lemtrada Use in RRMS Patients, FDA Reports
  • MS Foundation Partnering with ThermApparel to Provide Cooling Vests to Patients
Our Most Recent Posts
  • Back to the World April 13, 2018

    Primary progressive ms and steroid treatment

    primary progressive ms and steroid treatment

    Media:

    primary progressive ms and steroid treatmentprimary progressive ms and steroid treatmentprimary progressive ms and steroid treatmentprimary progressive ms and steroid treatmentprimary progressive ms and steroid treatment

http://buy-steroids.org